Biomea Fusion Net Worth
Biomea Fusion Net Worth Breakdown | BMEA |
Biomea Fusion Net Worth Analysis
Biomea Fusion's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Biomea Fusion's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Biomea Fusion's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Biomea Fusion's net worth analysis. One common approach is to calculate Biomea Fusion's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Biomea Fusion's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Biomea Fusion's net worth. This approach calculates the present value of Biomea Fusion's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Biomea Fusion's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Biomea Fusion's net worth. This involves comparing Biomea Fusion's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Biomea Fusion's net worth relative to its peers.
Enterprise Value |
|
To determine if Biomea Fusion is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Biomea Fusion's net worth research are outlined below:
| Biomea Fusion had very high historical volatility over the last 90 days | |
| Biomea Fusion may become a speculative penny stock | |
| Biomea Fusion has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (138.43 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Biomea Fusion currently holds about 149.63 M in cash with (119.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.11, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Biomea Fusion has a frail financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: Biomea Fusion Appoints Julianne Averill to its Board of Directors |
Biomea Fusion uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Biomea Fusion. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Biomea Fusion's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 26th of March 2024 Upcoming Quarterly Report | View | |
| 7th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Biomea Fusion's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Biomea Fusion is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Biomea Fusion backward and forwards among themselves. Biomea Fusion's institutional investor refers to the entity that pools money to purchase Biomea Fusion's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Two Sigma Investments Llc | 2025-03-31 | 472.4 K | Northern Trust Corp | 2025-03-31 | 297.6 K | Millennium Management Llc | 2025-03-31 | 281.7 K | Renaissance Technologies Corp | 2025-03-31 | 278.1 K | Nuveen, Llc | 2025-03-31 | 270.1 K | Aqr Capital Management Llc | 2025-03-31 | 264 K | Woodline Partners Lp | 2025-03-31 | 240.8 K | Ubs Group Ag | 2025-03-31 | 236.9 K | Charles Schwab Investment Management Inc | 2025-03-31 | 181.4 K | Fmr Inc | 2025-03-31 | 5.4 M | Cormorant Asset Management, Llc | 2025-03-31 | 3.6 M |
Follow Biomea Fusion's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 104.35 M.Market Cap |
|
Project Biomea Fusion's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.73) | (1.82) | |
| Return On Capital Employed | (2.47) | (2.35) | |
| Return On Assets | (1.73) | (1.82) | |
| Return On Equity | (2.68) | (2.55) |
When accessing Biomea Fusion's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Biomea Fusion's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Biomea Fusion's profitability and make more informed investment decisions.
Please note, the presentation of Biomea Fusion's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Biomea Fusion's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Biomea Fusion's management manipulating its earnings.
Evaluate Biomea Fusion's management efficiency
Biomea Fusion has return on total asset (ROA) of (0.7421) % which means that it has lost $0.7421 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.5681) %, meaning that it created substantial loss on money invested by shareholders. Biomea Fusion's management efficiency ratios could be used to measure how well Biomea Fusion manages its routine affairs as well as how well it operates its assets and liabilities. As of July 29, 2025, Return On Tangible Assets is expected to decline to -1.82. The current year's Return On Capital Employed is expected to grow to -2.35. At present, Biomea Fusion's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 10.6 M, whereas Net Tangible Assets are forecasted to decline to about 80.4 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.43 | 2.41 | |
| Tangible Book Value Per Share | 1.43 | 2.42 | |
| Enterprise Value Over EBITDA | (0.66) | (0.70) | |
| Price Book Value Ratio | 2.72 | 2.85 | |
| Enterprise Value Multiple | (0.66) | (0.70) | |
| Price Fair Value | 2.72 | 2.85 | |
| Enterprise Value | 81.5 M | 61.6 M |
Biomea Fusion benefits from a proactive management team that anticipates market trends. Our analysis delves into how this proactive stance influences financial metrics and stock valuation.
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Biomea Fusion insiders, such as employees or executives, is commonly permitted as long as it does not rely on Biomea Fusion's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Biomea Fusion insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Biomea Fusion time-series forecasting models is one of many Biomea Fusion's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Biomea Fusion's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Biomea Fusion Earnings per Share Projection vs Actual
Biomea Fusion Corporate Management
| Juan MD | Chief Officer | Profile | |
| Caroline Dupont | Senior Contracts | Profile | |
| Stephan MD | Chief Officer | Profile | |
| Franco Valle | CFO Officer | Profile | |
| Ravi Upasani | Executive Property | Profile | |
| Ramses Erdtmann | President, CoFounder | Profile | |
| Thomas Butler | Chairman CoFounder | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomea Fusion. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade Biomea Stock refer to our How to Trade Biomea Stock guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomea Fusion. If investors know Biomea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomea Fusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Biomea Fusion is measured differently than its book value, which is the value of Biomea that is recorded on the company's balance sheet. Investors also form their own opinion of Biomea Fusion's value that differs from its market value or its book value, called intrinsic value, which is Biomea Fusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomea Fusion's market value can be influenced by many factors that don't directly affect Biomea Fusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomea Fusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomea Fusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomea Fusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.